Buscar
Mostrando ítems 1-10 de 584
How much survival benefit is necessary for breast cancer patients to opt for adjuvant chemotherapy? Results from a Chilean survey
(2014)
Background: Breast cancer (BC) is the leading cause of cancer death in Chilean women. Adjuvant chemotherapy decreases recurrence and death from BC. The recommendation to indicate chemotherapy is complex. Adjuvant! Online ...
Benefit of adjuvant 5-fluorouracil based chemotherapy for colon cancer: a retrospective cohort study
(SOC MEDICA SANTIAGO, 2016)
Background: Multiple clinical trials have demonstrated the benefits of adjuvant 5-fluorouracil-based chemotherapy for patients with resectable colon cancer (CC), especially in stage III. Aim: To describe the clinical ...
Do you know this syndrome? Hand-foot syndrome
(2017-01-01)
Hand-foot syndrome is a common cutaneous adverse effect associated with certain systemic chemotherapy drugs. It is characterized by erythema, edema, and burning sensation, especially over palmoplantar surfaces. We report ...
Recaída de enfermedad de Hodgkin en adulto tras 17 años de remisión completa continua: Caso clínico
(Sociedad Médica de Santiago, 2003)
Radio-quimioterapia postoperatoria en cáncer gástrico localmente avanzado
(Sociedad Médica de Santiago, 2008)
Association between immunohistochemical expression of topoisomerase II alpha, HER2 and hormone receptors and response to primary chemotherapy in breast cancer
(Pensiero Scientifico EditorRomeItália, 2006)
Timing Of Adjuvant Chemotherapy In Colorectal Cancer
(Wiley-BlackwellHoboken, 2016)
Ejercicio físico en mujeres con cáncer de mama
(Sociedad Médica de Santiago, 2010)
Adjuvant thalidomide and metronomic chemotherapy for the treatment of canine malignant mammary gland neoplasms
(2018-11-01)
Background/Aim: The aim of the present study was to evaluate a multimodal approach for the treatment of canine malignant mammary gland neoplasms, including surgery, chemotherapy, thalidomide, and metronomic chemotherapy ...
Perfiles de expresión génica en decisiones terapéuticas en cáncer de mama
(Sociedad Médica de Santiago, 2007)